- Breaking Down Barriers to HIV Medication Access
Researchers investigated whether home delivery of ART for a modest fee could help improve ART access and use, finding it resulted in increased viral suppression in participants compared with clinic-based medication distribution.
- Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use disorder
A long-acting antiretroviral treatment given every four to eight weeks, and delivered with comprehensive support services, suppressed HIV in people who were previously not virologically suppressed.
- Attention to Geometric Images May Offer Biomarker for Some Toddlers with Autism
An NIMH-supported study shows that preference for geometric images may be robust enough to serve as a biomarker for identifying some young children with autism.
- NIMH Researcher Karen Berman Elected as AAAS Fellow
Karen Berman, M.D., a senior investigator at the National Institute of Mental Health (NIMH), has been elected as a 2022 American Association for the Advancement of Science (AAAS) Fellow.
- COVID-19 Pandemic Associated With Worse Mental Health and Accelerated Brain Development in Adolescents
An NIMH-supported study suggests that adolescents living through the COVID-19 pandemic may be experiencing more anxiety and depression symptoms and accelerated brain aging.
- Brief Cognitive Training May Extend the Antidepressant Effects of Ketamine
An NIMH-supported study suggests that a brief self-association training program can extend the effects of a single ketamine infusion by shifting people’s negative self-beliefs.
- NIMH Creates Publicly Accessible Resource With Data From Healthy Volunteers
The NIMH Healthy Research Volunteer Study aims to build a comprehensive, publicly accessible resource with a range of brain and behavioral data from healthy volunteers.
- Barriers and Supports to HIV Prevention Among Young Women in Kenya
In a qualitative study supported by NIMH, researchers identified barriers and supports to Kenyan women’s use of PrEP, a highly effective medication to reduce HIV transmission.
- T Cells Help HIV Enter and Persist in the Brain
A recent NIMH-supported study sheds light on the role of a unique set of T cells in trafficking HIV infection into the brain and mediating the virus’ persistence there.
- Researchers Map the Genetic Landscape of Schizophrenia in the Brain
In a comprehensive postmortem genetic analysis of the caudate nucleus in the brain, NIMH-supported researchers identified many genes associated with schizophrenia risk, including a gene that regulates the flow of the chemical messenger dopamine.